Clinical Trial Update: Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating intraperitoneal paclitaxel and carboplatin in women with carcinoma of Mullerian origin starting with ovarian carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Ovarian Carcinoma | Phase 2 | Status: COMPLETED